Not only do I not have any of them, I don’t even know what they are,
A recent Cell paper used R&D Systems Anti-Human ACE-2 Antibody to show that the coronavirus responsible for COVID-19, SARS-CoV-2, uses ACE-2 as an entry receptor.
www.rndsystems.com
Identification and Characterization of SARS-CoV-2
Identification and sequencing of the virus responsible for COVID-19 (
view SARS-CoV-2 protein sequence) determined that it was a novel CoV that shared 88% sequence identity with two bat-derived SARS-like CoV, suggesting it had originated in bats.10 Additionally, it was shown that this CoV, which was termed 2019-nCoV or SARS-CoV-2, shared 79.5% sequence identity with SARS-CoV.5,10 The coronaviral genome encodes four major structural proteins: the spike (S) protein, nucleocapsid (N) protein, membrane (M) protein, and the envelope (E) protein.6 The S protein is responsible for facilitating entry of the CoV into the target cell. It is composed of a short intracellular tail, a transmembrane anchor, and a large ectodomain that consists of a receptor binding S1 subunit and a membrane-fusing S2 subunit.11 Sequence analysis of the SARS-CoV-2 S protein genome showed that it was only 75% identical with the SARS-CoV S protein.5,10 However, analysis of the receptor binding motif (RBM) in the S protein showed that most of the amino acid residues essential for receptor binding were conserved between SARS-CoV and SARS-CoV-2, suggesting that the 2 CoV strains use the same host receptor for cell entry.12
The entry receptor utilized by SARS-CoV is Angiotensin-Converting Enzyme 2 (ACE-2).13
ACE-2
ACE-2 is a type I transmembrane metallocarboxypeptidase with homology to
ACE, an enzyme long-known to be a key player in the
Renin-Angiotensin system (RAS) and a target for the treatment of hypertension.14 I
t is mainly expressed in vascular endothelial cells, the renal tubular epithelium, and in Leydig cells in the testes.15,16 PCR analysis revealed that ACE-2 is also expressed in the lung, kidney, and gastrointestinal tract, tissues shown to harbor SARS-CoV.17-19 The major substrate for
ACE-2 is
Angiotensin II.20
ACE-2 degrades
Angiotensin II to generate
Angiotensin 1-7, thereby, negatively regulating RAS.15,20
ACE-2 has also been shown to exhibit a protective function in the cardiovascular system and other organs.15
ACE-2 is an Entry Receptor for SARS-CoV-2
Based on the sequence similarities of the RBM between SARS-CoV-2 and SARS-CoV,
several independent research groups investigated if SARS-CoV-2 also utilizes ACE-2 as a cellular entry receptor. Zhou
et al. showed that SARS-CoV-2 could use
ACE-2 from humans, Chinese horseshoe bats, civet cats, and pigs to gain entry into ACE-2-expressing HeLa cells.5 Hoffmann
et al. reported similar findings for human and bat
ACE-2.21 Additionally, Hoffmann
et al. showed that treating Vero-E6 cells, a monkey kidney cell line known to permit SARS-CoV replication, with an
Anti-ACE-2 Antibody (R&D Systems, Catalog #
AF933) blocked entry of VSV pseudotypes expressing the SARS-CoV-2 S protein.21